CBRE vs Cushman & Wakefield
CBRE and CWK side by side, both in real estate. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBRE and CWK compare
CBRE is the larger company, worth 12 times as much as Cushman & Wakefield ($37.3B against $3.1B).
On earnings, CBRE is cheaper: it trades at 29.6× trailing earnings, against 44.3× for Cushman & Wakefield.
CBRE grew revenue faster over the last twelve months (14.7% versus 11.0% for Cushman & Wakefield).
CBRE keeps more of each dollar of sales as profit, with a net margin of 3.0% compared with 0.64% at Cushman & Wakefield.
CBRE scores higher on the StockData Score (11 against 5 for Cushman & Wakefield), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBRE | CWK |
|---|---|---|
| Size and price | ||
| Market cap | $37.3B | $3.1B |
| Share price | $128.85 | $13.30 |
| Change, 1 year | −15.6% | −19.5% |
| Change, 5 years | 20.8% | −33.4% |
| Beta (5Y) | 1.05 | 1.54 |
| Employees | 155K | 53K |
| StockData Score | ||
| Total score | 11 (better) | 5 |
| Valuation score | 2 (better) | 1 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 1 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 29.6× (better) | 44.3× |
| P/S | 0.9× | 0.3× (better) |
| P/B | 4.4× | 1.5× (better) |
| EV/EBITDA | 16.3× | 9.1× (better) |
| P/FCF | 39.8× | 12.5× (better) |
| FCF yield | 2.5% | 8.0% (better) |
| Fair value | $89.01 | $9.34 |
| Margin of safety | −44.8% | −42.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 14.7% (better) | 11.0% |
| Revenue growth, 5Y average | 11.2% (better) | 5.6% |
| Net income growth (TTM) | 19.4% (better) | −66.4% |
| EPS growth (TTM) | 22.1% (better) | −65.9% |
| EPS growth, 5Y average | 11.6% | – |
| Profitability | ||
| Gross margin | 18.4% (better) | 18.1% |
| Operating margin | 4.5% (better) | 4.4% |
| Net margin | 3.0% (better) | 0.64% |
| FCF margin | 2.1% | 2.3% (better) |
| Return on equity | 15.6% (better) | 3.5% |
| Return on invested capital | 10.8% (better) | 8.9% |
| Financial health | ||
| Debt / equity | 0.96 (better) | 1.31 |
| Net debt / EBITDA | 2.43 (better) | 3.70 |
| Interest coverage | – | 2.2× |
| Current ratio | 1.14 (better) | 1.08 |
| Altman Z-score | 3.20 (better) | 1.85 |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 3.3% | – |
| Shareholder yield | 3.3% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 98.2% | 96.2% |
| Held by insiders | 2.8% | 1.5% |
| Insider net buying, 12 months | −$2.7M | −$989K (better) |
| Superinvestors holding | 4 (better) | 1 |
| Short interest, % of float | 1.6% | 6.5% |
Go deeper
- CBRE stock overview
- CBRE income statement
- CBRE valuation and score
- CWK stock overview
- CWK income statement
- CWK valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.